10.1371/journal.pone.0185099.g007 Atefeh Razazan Atefeh Razazan Javad Behravan Javad Behravan Atefeh Arab Atefeh Arab Nastaran Barati Nastaran Barati Leila Arabi Leila Arabi Zahra Gholizadeh Zahra Gholizadeh Mahdi Hatamipour Hatamipour Amin Reza Nikpoor Amin Reza Nikpoor Amir Abbas Momtazi-Borojeni Amir Abbas Momtazi-Borojeni Fatemeh Mosaffa Fatemeh Mosaffa Mohamad Hosein Ghahremani Mohamad Hosein Ghahremani Mahmoud Reza Jaafari Mahmoud Reza Jaafari Therapeutic effects of liposomal formulations in BALB/c mice against a TUBO tumor model. Public Library of Science 2017 Lip-DOPE-MPL-GP 2 formulation DMPG DMPC breast IFN mice xenograft model TUBO mice model GP 2 peptide vaccine fusogenic lipid dioleoylphosphatidylethanolamine increase cytotoxic T lymphocyte CTL delivery system Maleimide-mPEG 2000- DSPE micelles HER BALB intracellular cytokine analysis adjuvant response 2017-10-18 17:38:37 Figure https://plos.figshare.com/articles/figure/Therapeutic_effects_of_liposomal_formulations_in_BALB_c_mice_against_a_TUBO_tumor_model_/5511064 <p>Two weeks after inoculation of 5 ×10<sup>5</sup> TUBO cells to five mice in each group, different liposomal formulations were administrated three times with two-week intervals. After the first injection, the mice were challenged and tumor size was calculated based on three dimensions. (A) Tumor growth was measured two times every week. (B) The survival of mice was followed for 91 days. The data indicate the mean ±SEM(n = 5). ***<i>p</i><0.001 and ****<i>p</i><0.0001; denote significant difference from the HEPS-dextrose 5% group.</p>